Johnson & Johnson has announced the opening of JLABS in Shanghai, the world's largest JLABS and the first in Asia Pacific. The roughly 47,000 sq. ft. facility, located in Shanghai's Zhangjiang Hi-Tech Park, is a collaboration with the Shanghai

Historically, manufacturers have used a 'waterfall' approach when designing and building their production facilities, sequentially resolving and specifying all aspects up front and in detail for each project, over and over again. These projects ca

An explosion in a biotech workshop in central China's Henan Province has left six people dead, local authorities said. The blast, which occurred at Xumei Biotech Co. Ltd., killed five instantly. Another died in hospital, said the local emergency m

Novavax and Catalent Biologics' Paragon Gene Therapy unit have announced a strategic partnership. Under the terms of the agreement, Paragon Gene Therapy will assume the leases on two Novavax product development and manufacturing facilities, purcha

A decade ago, Congress passed a law meant to encourage development of cheaper biosimilars. These near-copies of complex and expensive biologics to treat cancer, rare diseases, autoimmune disorders and more were supposed to save the U.S. tens of bi

A U.S. Patent for a "Solventless Extraction Process" was awarded to DSM on June 25th, 2019. The present invention provides a method for extracting lipids from microorganisms without using organic solvent as an

Mile High Labs, the largest manufacturer of CBD isolate in the world, has announced the purchase of Novartis' 400,000 square foot production facility in Broomfield, Colorado. The transaction includes the land, labs, building, and ready-to-use fini

A U.S. Patent for "Conditionally Active Biological Proteins" was awarded to BioAtla on June 25th, 2019. The present invention is a method of preparing a conditionally active biological protein, the method comp

AbbVie has made public plans to acquire Allergan for about $63 billion, in one of the biggest mergers in the health care industry this year. In acquiring Allergan, AbbVie gets to bypass the risky process of research and development by buying a por

Drugmakers and industry groups are calling for changes to the U.S. FDA's draft guidance on bioavailability (BA) studies submitted as part of an investigational new drug (IND) application or new drug application (NDA). The 27-page draft guidance wa

A U.S. Patent Application for "Wireless Sensor Information Monitoring" was published by Lonza on June 20th, 2019. The present invention is a system, apparatus, and method for continuously monitoring data output

The NHS has announced that it is preparing to fast-track 'game changing' cancer drugs that target genetic mutations, targeting tumours according to their genetic make-up rather than where they originate in the body. The revolutionary treatments -

Alexion has announced the decision by the U.S. FDA to accept for priority review its long-acting C5 complement inhibitor, ravulizumab (Ultomiris), which offers less frequent administration than eculizumab. The FDA will review ravulizumab for the t

A U.S. Patent Application for "Packed Bed Emulsification" was published by GE on June 20th, 2019. The present invention is a system for the production of polysaccharide droplets from a water-in-oil emulsion co

Traditionally, scientists have used light, x-rays, and electrons to peer inside tissues and cells. Today, scientists can trace thread-like fibers of nerves throughout the brain and even watch living mouse embryos conjure the beating cells of a rud

Sanofi has made public plans for a "voluntary departure program" to reduce its R&D departments in France and Germany by 466 workers, as it shifts away from cardiovascular drug development and toward activities in immuno-oncology and rare disea

GSK has kicked off the sale of some consumer health brands as it seeks to raise about $1.26 billion before pressing ahead with a spinoff of its consumer healthcare business, sources told Reuters. The drugmaker has bundled the non-core drugs into t

The NHS has announced that it is preparing to fast-track 'game changing' cancer drugs that target genetic mutations, targeting tumours according to their genetic make-up rather than where they originate in the body. The revolutionary treatments -